Latanoprostene Bunod 0.024% versus Timolol Maleate 0.5% in Subjects with Open-Angle Glaucoma or Ocular Hypertension-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Latanoprostene Bunod 0.024% versus Timolol Maleate 0.5% in Subjects with Open-Angle Glaucoma or Ocular Hypertension

Published:2016-05 Issue:5 Volume:123 Page:965-973
ISSN:0161-6420
Container-title:Ophthalmology
language:en
Short-container-title:Ophthalmology

Author:

Weinreb Robert N.,Scassellati Sforzolini Baldo,Vittitow Jason^ORCID,Liebmann Jeffrey

Publisher

Elsevier BV

Subject

Ophthalmology

Reference36 articles.

1. Primary open-angle glaucoma;Weinreb;Lancet,2004

2. The pathophysiology and treatment of glaucoma: a review;Weinreb;JAMA,2014

3. An assessment of the health and economic burdens of glaucoma;Varma;Am J Ophthalmol,2011

4. Biostatistical analysis of the collaborative glaucoma study, I: summary report of the risk factors for glaucomatous visual-field defects;Armaly;Arch Ophthalmol,1980

5. The ocular hypertension treatment study: a randomized trial determines that topical hypotensive medication delays or prevents the onset of primary open angle glaucoma;Kass;Arch Ophthalmol,2002

Cited by 101 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. One-year experience with latanoprostene bunod ophthalmic solution 0.024% in clinical practice: A retrospective observational study;PLOS ONE;2024-08-22

2. A Randomized, Controlled Comparison of NCX 470, a Nitric Oxide-Donating Bimatoprost, and Latanoprost in Subjects with Open-Angle Glaucoma or Ocular Hypertension: The MONT BLANC Study;American Journal of Ophthalmology;2024-08

3. A Detailed Study of Glaucoma in Adults, Its Pathogenesis, Diagnosis and Management;Journal for Research in Applied Sciences and Biotechnology;2024-07-21

4. Effect of Latanoprostene Bunod on the Permeability of Trabecular Meshwork Cells;Journal of the Korean Ophthalmological Society;2024-02-15

5. Chemical Insights into Topical Agents in Intraocular Pressure Management: From Glaucoma Etiopathology to Therapeutic Approaches;Pharmaceutics;2024-02-15

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3